Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

• Main Authors: Linjie Pan (Author), Zhanchi Xu (Author), Min Wen (Author), Minghui Li (Author), Dongxin Lyu (Author), Haiming Xiao (Author), Zhuoming Li (Author), Junhui Xiao (Author), Yuanyuan Cheng (Author), Heqing Huang (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. Xinbao Pill (XBW), a traditional Chinese medicine formulation integrating "Liushen Pill" and "Shenfu Decoction," has been approved by China Food and Drug Administration for t...